Chief Executive Officer Joe Payne told investors at the Leerink Partners Global Healthcare Conference that the company has advanced its inhaled messenger RNA cystic fibrosis (CF) program through three ...
The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...
Arcturus Therapeutics (NASDAQ: ARCT) is gearing up to announce its quarterly earnings on Tuesday, 2026-03-03. Here's a quick ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) reported a fourth quarter loss of $1.03 per share and revenue of $7.2 million, as the messenger RNA medicines company ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today ...
Dr Tedros Adhanom Ghebreyesus said 'the virus is still changing and is still capable of causing new waves of diseases and death'. (AFP via Getty Images) The leader of the World Health Organization ...
Women walk past a coronavirus (COVID-19) themed mural on a street in Mumbai, India, March 28, 2023. REUTERS/Francis Mascarenhas A new coronavirus subvariant, XBB. 1.16, has been designated as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results